411 related articles for article (PubMed ID: 11032808)
1. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation.
Migliaccio A; Castoria G; Di Domenico M; de Falco A; Bilancio A; Lombardi M; Barone MV; Ametrano D; Zannini MS; Abbondanza C; Auricchio F
EMBO J; 2000 Oct; 19(20):5406-17. PubMed ID: 11032808
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth.
Migliaccio A; Varricchio L; De Falco A; Castoria G; Arra C; Yamaguchi H; Ciociola A; Lombardi M; Di Stasio R; Barbieri A; Baldi A; Barone MV; Appella E; Auricchio F
Oncogene; 2007 Oct; 26(46):6619-29. PubMed ID: 17486077
[TBL] [Abstract][Full Text] [Related]
4. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
5. Rapid signalling pathway activation by androgens in epithelial and stromal cells.
Castoria G; Lombardi M; Barone MV; Bilancio A; Di Domenico M; De Falco A; Varricchio L; Bottero D; Nanayakkara M; Migliaccio A; Auricchio F
Steroids; 2004 Aug; 69(8-9):517-22. PubMed ID: 15288763
[TBL] [Abstract][Full Text] [Related]
6. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
Castoria G; Barone MV; Di Domenico M; Bilancio A; Ametrano D; Migliaccio A; Auricchio F
EMBO J; 1999 May; 18(9):2500-10. PubMed ID: 10228164
[TBL] [Abstract][Full Text] [Related]
7. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
8. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.
Veldscholte J; Berrevoets CA; Ris-Stalpers C; Kuiper GG; Jenster G; Trapman J; Brinkmann AO; Mulder E
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):665-9. PubMed ID: 1562539
[TBL] [Abstract][Full Text] [Related]
9. 17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells.
Chieffi P; Kisslinger A; Sinisi AA; Abbondanza C; Tramontano D
Int J Oncol; 2003 Sep; 23(3):797-801. PubMed ID: 12888920
[TBL] [Abstract][Full Text] [Related]
10. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
11. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors.
Auricchio F; Migliaccio A; Castoria G
Steroids; 2008 Oct; 73(9-10):880-4. PubMed ID: 18342899
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells.
Maggiolini M; Recchia AG; Carpino A; Vivacqua A; Fasanella G; Rago V; Pezzi V; Briand PA; Picard D; Andò S
J Mol Endocrinol; 2004 Jun; 32(3):777-91. PubMed ID: 15171712
[TBL] [Abstract][Full Text] [Related]
13. Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/Src association.
Migliaccio A; Castoria G; Auricchio F
Methods Mol Biol; 2011; 776():361-70. PubMed ID: 21796537
[TBL] [Abstract][Full Text] [Related]
14. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between EGFR and extranuclear steroid receptors.
Migliaccio A; Castoria G; Di Domenico M; Ciociola A; Lombardi M; De Falco A; Nanayakkara M; Bottero D; De Stasio R; Varricchio L; Auricchio F
Ann N Y Acad Sci; 2006 Nov; 1089():194-200. PubMed ID: 17261767
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
17. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells.
Castoria G; Migliaccio A; Bilancio A; Di Domenico M; de Falco A; Lombardi M; Fiorentino R; Varricchio L; Barone MV; Auricchio F
EMBO J; 2001 Nov; 20(21):6050-9. PubMed ID: 11689445
[TBL] [Abstract][Full Text] [Related]
18. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
[TBL] [Abstract][Full Text] [Related]
19. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
20. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
Berns EM; de Boer W; Mulder E
Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
